About Wellinks
Wellinks is a company based in New Haven (United States) founded in 2013. Wellinks has raised $28.54 million across 6 funding rounds from investors including HighCape Capital, Connecticut Innovations and Stonehenge Capital. Wellinks has completed 2 acquisitions, including Sparo Health and Spire Health. Wellinks offers products and services including Virtual Pulmonary Rehabilitation and Predictive Patient Care. Wellinks operates in a competitive market with competitors including Resvent, Amiko, Qol Devices, Curatek and NorCal Respiratory, among others.
- Headquarter New Haven, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$28.54 M (USD)
in 6 rounds
-
Latest Funding Round
$2.43 M (USD), Series A
May 07, 2025
-
Investors
HighCape Capital
& 5 more
-
Employee Count
Not available
-
Investments & Acquisitions
Sparo Health
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Wellinks
Wellinks offers a comprehensive portfolio of products and services, including Virtual Pulmonary Rehabilitation and Predictive Patient Care.
Remote program for COPD patient monitoring and care.
System for early detection of respiratory issues.
People of Wellinks
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Wellinks
Wellinks has successfully raised a total of $28.54M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $2.43 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Wellinks
Wellinks has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include HighCape Capital, Connecticut Innovations and Stonehenge Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life science companies are targeted for private equity investments.
|
Locked | Locked | Locked | |
|
Venture capital services for biotech, IT, and innovative sectors in Connecticut.
|
Locked | Locked | Locked | |
|
US private equity investments are managed by Stonehenge Capital.
|
Locked | Locked | Locked |
Investor details for Wellinks
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Wellinks
Wellinks has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Sparo Health and Spire Health.
Investment portfolio details for Wellinks
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Wearable devices for continuous health monitoring are developed.
|
Locked | Locked | 2014 | Locked | |
|
App and smart spirometer for detecting lung health
|
Locked | Locked | 2012 | Locked |
Complete acquisition details for Wellinks
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Wellinks
Detailed financials for Wellinks
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Wellinks Comparisons
Peer comparison for Wellinks
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Wellinks
Wellinks operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Resvent, Amiko, Qol Devices, Curatek and NorCal Respiratory, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A suite of respiratory healthcare devices is developed.
|
|
| Locked | Locked | Locked |
Smart sensors are attached to medication devices for adherence tracking.
|
|
| Locked | Locked | Locked |
Breathing coaching devices for children with respiratory issues are provided.
|
|
| Locked | Locked | Locked |
Delivers devices for monitoring respiratory rates in medical settings.
|
|
| Locked | Locked | Locked |
Respiratory therapy devices for disorder treatment are provided.
|
Detailed competitors of Wellinks
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Wellinks
Complete news archive for Wellinks
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wellinks
Wellinks was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Wellinks is headquartered in New Haven, United States. It is registered at New Haven, Connecticut, United States.
Stacie Bratcher is the current CEO of Wellinks.
Wellinks is a funded company, having raised a total of $28.54M across 6 funding rounds to date.
Wellinks was founded in 2013 in New Haven, United States, and operates in the health technology sector. Connected wearable devices for COPD care are offered, featuring a smart strap that replaces standard velcro on braces. Usage duration and tightness are monitored in real time via a mobile app connection. Services include reporting, medication reminders, personalized health insights, and coaching support for patients, doctors, parents, and children.
Wellinks's top competitors include Resvent, NorCal Respiratory and Qol Devices.
Wellinks offers Virtual Pulmonary Rehabilitation and Predictive Patient Care.
Wellinks has made 2 acquisitions, including Sparo Health, and Spire Health.
Wellinks has 6 investors. Key investors include HighCape Capital, Connecticut Innovations, Stonehenge Capital, Benslie, and Morningside.